1. Home
  2. BCDA vs INTZ Comparison

BCDA vs INTZ Comparison

Compare BCDA & INTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioCardia Inc.

BCDA

BioCardia Inc.

HOLD

Current Price

$0.93

Market Cap

15.7M

Sector

Health Care

ML Signal

HOLD

Logo Intrusion Inc.

INTZ

Intrusion Inc.

HOLD

Current Price

$0.65

Market Cap

16.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCDA
INTZ
Founded
N/A
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Communications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
15.7M
16.2M
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
BCDA
INTZ
Price
$0.93
$0.65
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $15.50
N/A
AVG Volume (30 Days)
★ 218.9K
78.4K
Earning Date
11-11-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 71.78
EPS
★ N/A
N/A
Revenue
$479,000.00
★ $7,015,000.00
Revenue This Year
N/A
$22.62
Revenue Next Year
N/A
$26.44
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 21.56
52 Week Low
$0.75
$0.59
52 Week High
$1.80
$2.27

Technical Indicators

Market Signals
Indicator
BCDA
INTZ
Relative Strength Index (RSI) 35.15 39.06
Support Level $0.85 $0.60
Resistance Level $0.99 $0.91
Average True Range (ATR) 0.05 0.05
MACD -0.01 -0.01
Stochastic Oscillator 6.13 3.59

Price Performance

Historical Comparison
BCDA
INTZ

About BCDA BioCardia Inc.

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP autologous mononuclear cell therapy platform is being for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an off the shelf cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

About INTZ Intrusion Inc.

Intrusion Inc is a cybersecurity company based in Plano, Texas. The company offers its customers access to its exclusive threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol addresses. Its platform combines threat intelligence, malicious traffic identification, and automated threat response, and is designed to help organizations proactively identify and stop malicious activity in their networks. Its solutions include INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. The company operates in single segment.

Share on Social Networks: